Drug-Eluting Balloon or Drug-Eluting Stent in Acute Myocardial Infarction: A Randomized Controlled Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 598 participants.

Also called NCT06746233

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 598 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06746233
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Bosnia & Herzegovina, Serbia (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06746233. Randomized; no masking; primary purpose treatment. Start 2024-12-25 (actual); primary completion 2028-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Drug-Eluting Balloon or Drug-Eluting Stent in Acute Myocardial Infarction: A Randomized Controlled Trial
Acronym
BOOST-AMI
Condition
ST Elevation Myocardial Infarction (STEMI)
Intervention (Device)
Drug (paclitaxel) coated balloon (DCB)
Intervention (Device)
Second-generation Drug Eluting Stent (DES)
Lead sponsor
Institute of Cardiovascular Diseases, Vojvodina (class: other)

Record details

Record id
cardio:ct-nct06746233
Content hash
85a6d7aef85ece518717a1aef17c34e3ea603dfb8fa6081c53d30bc32d0ae69e